Showing results (21-30 of 29) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 29 results.
The Journal of Infectious Diseases|November 10, 2023
Whole-Genome Sequencing Predicting Phenotypic Antitubercular Drug Resistance: Meta-analysisYoichi Tagami, Nobuyuki Horita, Megumi Kaneko, et al.
Therapeutic Advances in Medical Oncology|September 18, 2023
Adverse events induced by durvalumab and tremelimumab combination regimens: a systematic review and meta-analysisHiromi Matsumoto, Kohei Somekawa, Nobuyuki Horita, et al.
Thoracic Cancer|December 6, 2021
Pembrolizumab monotherapy versus pembrolizumab plus chemotherapy in patients with non-small-cell lung cancer: A multicenter retrospective trialHiromi Matsumoto, Nobuaki Kobayashi, Kohei Somekawa, et al.
European Clinical Respiratory Journal|July 30, 2024
Efficacy and safety of benralizumab in elderly patients with severe eosinophilic asthmaKohei Somekawa, Keisuke Watanabe, Kenichi Seki, et al.
Translational Lung Cancer Research|April 11, 2024
Improved diagnostic accuracy with three lung tumor markers compared to six-marker panelAmi Izawa, Yu Hara, Nobuyuki Horita, et al.
Translational Lung Cancer Research|March 21, 2025
Rapid detection of non-small cell lung cancer driver mutations using droplet digital polymerase chain reaction analysis of bronchial washings: a prospective multicenter studyKohei Somekawa, Nobuaki Kobayashi, Satoshi Nagaoka, et al.
Thoracic Cancer|April 11, 2024
Real-world evidence of efficacy of pembrolizumab plus chemotherapy and nivolumab plus ipilimumab plus chemotherapy as initial treatment for advanced non-small cell lung cancerAyami Kaneko, Nobuaki Kobayashi, Kenji Miura, et al.
European Respiratory Review : an Official Journal of the European Respiratory Society|November 12, 2025
Valid surrogate end-points in nonsmall cell lung cancer peri-operative systemic therapy trials: a systematic reviewKohei Somekawa, Nobuyuki Horita, Satoshi Nagaoka, et al.
HLA|July 23, 2024
HLA-DQA1*01:03 and DQB1*06:01 are risk factors for severe COVID-19 pneumoniaKatsushi Tanaka, Akira Meguro, Yu Hara, et al.
Pageof 3